NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



Investigators at University of Ryukyus zero in on tuberculosis



April 8th, 2008

According to recent research published in the journal Vaccine, "It is generally accepted that cellular immunity plays a critical role in the protection against Mycobacterium tuberculosis, an intracellular pathogen. Recently, however, an increasing number of reports indicate the important contribution of humoral. immunity against mycobacterial. infection. Since M. tuberculosis establishes its primary lesion in the tung, induction of humoral. immunity in the airway tract by mucosal. immunization regime could provide protective immunity against tuberculosis."

"In this study, mycobacterial. heparin-binding haemagglutinin adhesin (HBHA) was used as an immunization...


Source: TB & Outbreaks Week (2008-04-08)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login